MATÉRIAUX Verre pharmaceutique PROTECTION ENFANT - CHILD-RESISTANCE Classification, procédés de fabrication… PHARMAGLASS RENFORCE LA SÉCURITÉ DES JEUNES UTILISATEURS Mais revenons au verre PHARMAGLASS STRENGTHENS THE SECURITY OF YOUNG USERSneutre et rentrons davan- tage dans le détail : le Pharmaglass a décidé ne parvenant pas à l’ouvrir bottle nipples and pipettes. verre neutre (ou borosili- d’accentuer la sécurité sur la en moins de 10 minutes). En These tamper-proof pipette cate) de type I contient capsule compte-gouttes des ne s’ouvrant qu’en combinant dropper capsules are complex des quantités importantes pipettes destinées aux enfants. une pression verticale sur products (no less than 4 de formateurs de réseaux Cette nouveauté, certifiée le bouchon simultanément parts) that guarantee the non- (oxydes de silice, d’alu- ISO 8317, est disponible sur avec une rotation axiale, elles breakage of the glass pipette minium et de bore). Les l’ensemble de la gamme de répondent aux exigences and its non-opening (tests contenants en verre de capsule pour flacon bague de la réglementation « child carried out with children aged type II sont particulière- 18DIN et est compatible avec resistant ». Elles sont 42 to 52 months failing to open ment adaptés à la plupart les tétines et les pipettes assemblées en salle propre. it in less than 10 minutes). des préparations aqueuses standard. Ces capsules compte- Opened only by combining the acides et neutres, pour gouttes pipettes inviolables Pharmaglass has decided application of vertical pressure usage parentéral ou non. sont des produits complexes to increase the safety of its on the cap simultaneously with Et les emballages en verre (pas moins de 4 pièces) qui pipette dropper capsule for an axial rotation, they meet de type III conviennent en garantissent la non-casse de children. This ISO 8317 certified the requirements of the “child- général pour les prépa- la pipette en verre et la non- innovation is available on the resistance” regulation. They are rations en véhicule non- ouverture (tests réalisés avec entire 18DIN bottle ring range assembled in a clean room. aqueux pour usage non- des enfants de 42 à 52 mois and is compatible with standard parentéral (sauf pour les manufactured in a single Solutions to secure the the mechanical resistance to for high value-added continuous process: the process shock of the Clareo vials has products. Furthermore, raw materials are melted been considerably improved. customers looking for a into glass in a furnace and Although glass is a very old With these products, SGD more economical alternative 76 then the glass is cut into material, it has been subject Pharma wanted to illustrate to converting Type I glass drops (gobs) that will form to constant developments. its expertise and perfect can find a more affordable the vials. The gobs are Thus, SGD Pharma command of the moulded solution in Clareo. This then cooked again in an introduced during the last glass manufacturing new range is available annealing oven to relieve the Pharmapack Europe edition process. “Our commitment in capacities of 20, 50 residual internal stresses in February its new premium is to continuously innovate and 100 ml in Type II and and are finally ready to be range of moulded glass vials and reinforce patient further developments are filled. in Type II, for injectable safety by improving the in progress,” SGD Pharma As for drawn glass solutions. These vials offer physical, chemical and says. “Clareo can also be containers, they are a unique combination of cosmetic properties of our available, on request, in manufactured in two homogeneous wall thickness different types of glass. Type III.” discontinuous stages: tubing and superior cosmetic This regularity allows a and forming of the final quality for moulded glass significant reduction of object. The molten glass is in Type II. These vials offer the breakage rate (up to Ever more significant stretched in the form of a technical characteristics 10x lower). Leading to an investments tube which, after cooling, similar to the vials in the improved inspectability is cut into glass tubes existing range and can before and after filling, Pharmaceutical glass measuring one metre fifty replace them without pharmaceutical and remains a material with long. In a second step, these any regulatory change. biotechnology companies a complex manufacturing glass tubes are transformed Moreover, due to the more benefit from this advantage, process and glass into finished products: homogeneous distribution of allowing for a reduction manufacturing are investing ampoules, vials, carpules (or the glass (+15 pts compared of their Total Cost of into it both in Europe cartridges) and syringes. to the standard process), Ownership (TCO), mostly and Asia. Thus, Schott Avril / Mai / Juin - 2018Doses 71 /Le Magazine du Packaging des Produits de Santé